These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17098062)

  • 1. Dying of diabetes.
    Gale EA
    Lancet; 2006 Nov; 368(9548):1626-8. PubMed ID: 17098062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes care in sub-Saharan Africa].
    Labie D
    Med Sci (Paris); 2007 Mar; 23(3):320-2. PubMed ID: 17349296
    [No Abstract]   [Full Text] [Related]  

  • 3. Pfizer dumps Exubera.
    Mack GS
    Nat Biotechnol; 2007 Dec; 25(12):1331-2. PubMed ID: 18066009
    [No Abstract]   [Full Text] [Related]  

  • 4. The market in diabetes.
    Hauber A; Gale EA
    Diabetologia; 2006 Feb; 49(2):247-52. PubMed ID: 16416145
    [No Abstract]   [Full Text] [Related]  

  • 5. Forging paths to improve diabetes care in low-income settings.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):565. PubMed ID: 28732660
    [No Abstract]   [Full Text] [Related]  

  • 6. The Insulin Boom. WHY THE COST OF THIS LIFESAVING DRUG IS REACHING NEW HEIGHTS.
    Tsai A
    Diabetes Forecast; 2016; 69(2):32-7. PubMed ID: 27048046
    [No Abstract]   [Full Text] [Related]  

  • 7. Economics of insulin.
    Shah SN
    J Assoc Physicians India; 2007 Jul; 55 Suppl():67-70. PubMed ID: 17927015
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled insulin: gone with the wind?
    Mathieu C; Gale EA
    Diabetologia; 2008 Jan; 51(1):1-5. PubMed ID: 18026925
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled insulin products puff along.
    Powell K
    Nat Biotechnol; 2004 Oct; 22(10):1195-6. PubMed ID: 15470441
    [No Abstract]   [Full Text] [Related]  

  • 10. Rising Costs of Drug/Insulin Treatment for Diabetes: A Perspective from India.
    Misra A; Mukherjee R; Luthra A; Singh P
    Diabetes Technol Ther; 2017 Dec; 19(12):693-698. PubMed ID: 29090974
    [No Abstract]   [Full Text] [Related]  

  • 11. Dying of diabetes.
    Hirst J
    Lancet; 2007 Feb; 369(9560):461; author reply 461-2. PubMed ID: 17292758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin analogues--which dimension should be discussed?].
    Verspohl EJ
    Med Monatsschr Pharm; 2006 Jun; 29(6):198-9. PubMed ID: 16792195
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes costs rise, but so does adherence.
    Manag Care; 2005 Apr; 14(4):54. PubMed ID: 15898213
    [No Abstract]   [Full Text] [Related]  

  • 14. PHARMAC and long-acting insulin analogues: a poor man's insulin pump--but not available to the poor man.
    Krebs J
    N Z Med J; 2005 Aug; 118(1221):U1641. PubMed ID: 16138177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes in the developing world.
    Lakhani Z
    BMJ; 1995 Feb; 310(6976):403. PubMed ID: 7866240
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosimilars for insulin: a cost-saving alternative?
    McCall C
    Lancet; 2018 Aug; 392(10146):463-464. PubMed ID: 30129449
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes research investment in the European Union.
    Halban PA; Ferrannini E; Nerup J
    Nat Med; 2006 Jan; 12(1):70-2. PubMed ID: 16397573
    [No Abstract]   [Full Text] [Related]  

  • 18. [Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
    Lüddeke HJ
    MMW Fortschr Med; 2006 Sep; 148(37):9. PubMed ID: 17036893
    [No Abstract]   [Full Text] [Related]  

  • 19. [The changeover to insulin U100. Clinical and pharmacoeconomic suggestions].
    Costa B
    Med Clin (Barc); 1996 Apr; 106(13):495-7. PubMed ID: 8992131
    [No Abstract]   [Full Text] [Related]  

  • 20. Stroke in sub-Saharan Africa: an urgent call for prevention.
    Chin JH
    Neurology; 2012 Mar; 78(13):1007-8. PubMed ID: 22454267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.